Penalty Amount
$300,000
Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all sales of unlawful 'research grade' GLP-1 weight loss drugs into the United States. The settlement prohibits manufacturers from advertising or selling GLP-1s to U.S. customers via the platform, requires a monitoring system to detect and remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements with entities including Triggered Brand, Radiance Medspa of Avon, and Advanced Medical Weight Loss of East Hartford were also announced for similar violations of Connecticut's Unfair Trade Practices Act.
Made-in-China is prohibited from allowing manufacturers to advertise or sell GLP-1 weight loss drugs to U.S. customers on its platform. The company must implement a monitoring system to detect and remove non-compliant listings, with all existing GLP-1 listings removed within five days. The company is subject to a $300,000 civil penalty, with $30,000 due initially and the remaining $270,000 suspended; full penalty imposition is triggered by any violation of settlement terms.
In-house legal teams for online trade platforms should review vendor agreements with third-party sellers to ensure they explicitly prohibit listing unapproved FDA-regulated drugs, prescription-only medications sold without valid verification, and products deceptively marketed as FDA-approved or generic equivalents. These agreements should include clauses requiring sellers to certify compliance with all applicable FDA regulations, grant the platform authority to monitor listings for non-compliant content, and mandate removal of violating listings within a short specified timeframe. Platform terms of service should incorporate penalty provisions for violations, including suspended fines triggered by non-compliance, seller account suspension, and reimbursement of enforcement costs. For healthcare provider entities like medspas, customer agreements and advertising contracts should be reviewed to ban promotion of unapproved compounded drugs and ensure robust prescription verification processes.
Entity
Made-in-China
Industry
Other"Made-in-China"
"$300,000 penalty to the state, suspended after $30,000"
"violations of the Connecticut Unfair Trade Practices Act"
"05/06/2026"
"Connecticut"
"settlement agreement"
Connecticut’s legislature passed House Bill 5312, creating new civil enforcement mechanisms for deepfake digital sexual assault, including unauthorized dissemination of synthetically created intimate images and AI-generated child pornography. The bill establishes a private right of action for victims and empowers the Connecticut Attorney General to pursue civil injunctions and penalties against abusers and platforms hosting illegal content. This builds on prior Connecticut laws criminalizing unauthorized intimate image dissemination.
Connecticut Attorney General William Tong issued a statement on May 1, 2026, announcing the final passage of bipartisan legislation targeting youth social media addiction and artificial intelligence harms. The legislation imposes new obligations on social media companies regarding minor account settings, parental consent, and reporting, as well as requirements for AI chatbot operators and employers using automated decision tools. The statement also references ongoing enforcement actions against Meta and TikTok for allegedly designing addictive platform features for youth.
On April 28, 2026, Connecticut Attorney General William Tong joined a bipartisan coalition of 24 other state attorneys general and New York City in sending letters to major credit card companies and payment processors urging them to block transactions facilitating illegal vaping product sales. The coalition highlighted that most vapor products lack required FDA authorization and many online sellers violate the federal Prevent All Cigarette Trafficking (PACT) Act, including failing to implement youth access safeguards. The coalition requested a meeting to discuss prohibiting noncompliant merchants from using payment networks, building on existing state enforcement actions against illegal vape sellers.
Connecticut Attorney General William Tong announced a settlement with beauty retailer Sephora resolving an investigation into the company’s marketing of anti-aging skincare products containing active ingredients like retinol to children under 13. Sephora agreed to adopt enforceable safeguards including requiring suppliers to provide age suitability warnings, disclosing those warnings on product pages, training employees to advise young customers, and maintaining a public resource on age-appropriate products. No monetary penalty was imposed.
On April 17, 2026, Connecticut Attorney General William Tong joined a coalition of 23 state attorneys general in sending a comment letter to CFPB Acting Director Russell Vought opposing the CFPB’s proposed strategic plan, which would drastically reduce agency staffing, weaken supervision of financial institutions, and curtail enforcement capacity. The coalition argues the plan would abdicate the CFPB’s statutory obligations, leave consumers vulnerable to fraud and scams, and shift enforcement burden to state agencies. The letter urges the CFPB to reverse course and maintain robust consumer protection efforts.
$100K
The Connecticut Attorney General announced a $100,000 settlement with Spruce Power 3, LLC to resolve an investigation into billing, customer service, and warranty issues stemming from consumer complaints. The settlement includes refunds for improper charges and requires reforms to improve billing practices and response times. Separately, an investigation was initiated into SunStrong Management LLC based on approximately 65 consumer complaints regarding warranty failures, unresponsiveness, and fees.